This viewpoint article critiques two recent articles examining ‘willingness to risk death’ to advance HIV cure-related research. The ‘willingness to risk death’ endpoint sends the wrong signal to the HIV cure-related research community about ongoing research in otherwise healthy volunteers living with HIV. Socio-behavioural scientists have examined the acceptability of a 99% risk of death scenario, which is unrealistic and would not be acceptable by current regulatory and ethical standards.
We believe that the field needs robust and relevant socio-behavioural research reflecting ongoing biomedical HIV cure-related trials. These studies will need to withstand regulatory and ethical scrutiny if cure or remission regimens are to proceed to the licensing stage.
The HIV cure-related research community must continue to protect the public trust in the HIV cure-related research field and sustain societal value generated by such research. We call for the utmost prudence in designing biomedical HIV cure trials as well as in setting up socio-behavioural research experiments related to these complex trials.
Left behind: persons with disabilities in HIV prevalence research and national strategic plans in east and Southern Africa.
Purpose: To assess recent estimates of HIV prevalence and the inclusion of persons with disabilities in the HIV response in sub-Saharan Africa.
Methods: A systematic literature search was conducted of recent HIV prevalence studies among persons with disabilities in sub-Saharan Africa and National Strategic Plans from 18 countries in east and southern Africa were reviewed. Results were compared to a 2014 literature search and a 2009 National Strategic Plans review that used similar methods.
Results: Between 2013 and 2018, four published studies were identified with estimates of HIV prevalence among persons with disabilities in sub-Saharan Africa. In each study, HIV prevalence was higher among persons with disabilities than national population estimates. Fourteen of the 18 National Strategic Plans reviewed identified persons with disabilities as a vulnerable or marginalized population and thirteen National Strategic Plans proposed targeted programs for persons with disabilities. Among seven assessed disability inclusion indicators of National Strategic Plans, four showed some improvement, two showed no change, and one regressed compared to the 2009 analysis.
RhoA Activation Assay |
|||
STA-403-A | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Rho Activation Assays use visible agarose beads to selectively precipitate the active form of RhoA, RhoB or RhoC. The precipitated small GTPase is then detected by Western blot using a RhoA-, RhoB- or RhoC-specific antibody included in the kit. |
|||
RhoB Activation Assay |
|||
STA-403-B | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Rho Activation Assays use visible agarose beads to selectively precipitate the active form of RhoA, RhoB or RhoC. The precipitated small GTPase is then detected by Western blot using a RhoA-, RhoB- or RhoC-specific antibody included in the kit. |
|||
RhoC Activation Assay |
|||
STA-403-C | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Rho Activation Assays use visible agarose beads to selectively precipitate the active form of RhoA, RhoB or RhoC. The precipitated small GTPase is then detected by Western blot using a RhoA-, RhoB- or RhoC-specific antibody included in the kit. |
|||
Arf1 Activation Assay |
|||
STA-407-1 | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Arf Activation Assays use visible agarose beads to selectively precipitate the active form of Arf1 or Arf 6. The precipitated small GTPase is then detected by Western blot using an Arf1- or Arf6-specific antibody included in the kit. |
|||
Arf6 Activation Assay |
|||
STA-407-6 | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Arf Activation Assays use visible agarose beads to selectively precipitate the active form of Arf1 or Arf 6. The precipitated small GTPase is then detected by Western blot using an Arf1- or Arf6-specific antibody included in the kit. |
|||
Ral Activation Assay |
|||
STA-408 | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Ral Activation Assay uses visible agarose beads to selectively precipitate the active form of Ral protein. The precipitated small GTPase is then detected by Western blot using a Ral-specific antibody included in the kit. |
|||
Ran Activation Assay |
|||
STA-409 | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Ran Activation Assay uses visible agarose beads to selectively precipitate the active form of Ran protein. The precipitated small GTPase is then detected by Western blot using a Ran-specific antibody included in the kit. |
|||
Pan-Ras Activation Assay |
|||
STA-400 | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Ras Activation Assays use visible agarose beads to selectively precipitate the active form of specific Ras protein of interest. The precipitated small GTPase is then detected by Western blot using a target-specific antibody included in the kit. Assays are available to detect specific isoforms H-Ras, K-Ras, and N-Ras, as well as a Pan-Ras assay that detects all three isoforms. |
|||
H-Ras Activation Assay |
|||
STA-400-H | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Ras Activation Assays use visible agarose beads to selectively precipitate the active form of specific Ras protein of interest. The precipitated small GTPase is then detected by Western blot using a target-specific antibody included in the kit. Assays are available to detect specific isoforms H-Ras, K-Ras, and N-Ras, as well as a Pan-Ras assay that detects all three isoforms. |
|||
K-Ras Activation Assay |
|||
STA-400-K | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Ras Activation Assays use visible agarose beads to selectively precipitate the active form of specific Ras protein of interest. The precipitated small GTPase is then detected by Western blot using a target-specific antibody included in the kit. Assays are available to detect specific isoforms H-Ras, K-Ras, and N-Ras, as well as a Pan-Ras assay that detects all three isoforms. |
|||
N-Ras Activation Assay |
|||
STA-400-N | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Ras Activation Assays use visible agarose beads to selectively precipitate the active form of specific Ras protein of interest. The precipitated small GTPase is then detected by Western blot using a target-specific antibody included in the kit. Assays are available to detect specific isoforms H-Ras, K-Ras, and N-Ras, as well as a Pan-Ras assay that detects all three isoforms. |
|||
Rap1 Activation Assay Kit |
|||
STA-406-1 | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Rap Activation Assays use visible agarose beads to selectively precipitate the active form of Rap1 or Rap2. The precipitated small GTPase is then detected by Western blot using a Rap1- or Rap2-specific antibody included in the kit. |
|||
Rap2 Activation Assay Kit |
|||
STA-406-2 | Cell Biolabs | 20 assays | 908.4 EUR |
Description: Our Rap Activation Assays use visible agarose beads to selectively precipitate the active form of Rap1 or Rap2. The precipitated small GTPase is then detected by Western blot using a Rap1- or Rap2-specific antibody included in the kit. |
|||
0.5ML Insite Markers |
|||
NAT1276 | Scientific Laboratory Supplies | 0.5ML | 202.92 EUR |
NK cell antibody (FITC) |
|||
61R-1160 | Fitzgerald | 100 ug | 262.8 EUR |
Description: Syrian Hamster monoclonal NK cell antibody (FITC) |
|||
NK cell antibody (PE) |
|||
61R-1398 | Fitzgerald | 100 ug | 360 EUR |
Description: Syrian Hamster monoclonal NK cell antibody (PE) |
|||
NK cell antibody (biotin) |
|||
61R-1643 | Fitzgerald | 100 ug | 340.8 EUR |
Description: Syrian Hamster monoclonal NK cell antibody (biotin) |
|||
Rac1 Activation Assay Kit, Trial Size |
|||
STA-401-1-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Rac Activation Assays use visible agarose beads to selectively precipitate the active form of Rac1 or Rac2. The precipitated small GTPase is then detected by Western blot using a Rac1- or Rac2-specific antibody included in the kit. |
|||
Rac2 Activation Assay Kit, Trial Size |
|||
STA-401-2-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Rac Activation Assays use visible agarose beads to selectively precipitate the active form of Rac1 or Rac2. The precipitated small GTPase is then detected by Western blot using a Rac1- or Rac2-specific antibody included in the kit. |
|||
Cdc42 Activation Assay Kit, Trial Size |
|||
STA-402-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Cdc42 Activation Assays use visible agarose beads to selectively precipitate the active form of Cdc42 protein. The precipitated small GTPase is then detected by Western blot using a Cdc42-specific antibody included in the kit. |
|||
RhoA Activation Assay Kit, Trial Size |
|||
STA-403-A-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Rho Activation Assays use visible agarose beads to selectively precipitate the active form of RhoA, RhoB or RhoC. The precipitated small GTPase is then detected by Western blot using a RhoA-, RhoB- or RhoC-specific antibody included in the kit. |
|||
RhoB Activation Assay Kit, Trial Size |
|||
STA-403-B-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Rho Activation Assays use visible agarose beads to selectively precipitate the active form of RhoA, RhoB or RhoC. The precipitated small GTPase is then detected by Western blot using a RhoA-, RhoB- or RhoC-specific antibody included in the kit. |
|||
RhoC Activation Assay Kit, Trial Size |
|||
STA-403-C-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Rho Activation Assays use visible agarose beads to selectively precipitate the active form of RhoA, RhoB or RhoC. The precipitated small GTPase is then detected by Western blot using a RhoA-, RhoB- or RhoC-specific antibody included in the kit. |
|||
Rac1/Cdc42 Activation Assay Combo Kit |
|||
STA-404 | Cell Biolabs | 2 x 20 assays | 1305.6 EUR |
Description: Our Rac1/Cdc42 Activation Assays use visible agarose beads to selectively precipitate the active form of the small GTPase. The precipitated small GTPase is then detected by Western blot using a specific antibody included in the kit. |
|||
Rap1 Activation Assay Kit, Trial Size |
|||
STA-406-1-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Rap Activation Assays use visible agarose beads to selectively precipitate the active form of Rap1 or Rap2. The precipitated small GTPase is then detected by Western blot using a Rap1- or Rap2-specific antibody included in the kit. |
|||
Rap2 Activation Assay Kit, Trial Size |
|||
STA-406-2-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Rap Activation Assays use visible agarose beads to selectively precipitate the active form of Rap1 or Rap2. The precipitated small GTPase is then detected by Western blot using a Rap1- or Rap2-specific antibody included in the kit. |
|||
Arf1 Activation Assay Kit, Trial Size |
|||
STA-407-1-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Arf Activation Assays use visible agarose beads to selectively precipitate the active form of Arf1 or Arf 6. The precipitated small GTPase is then detected by Western blot using an Arf1- or Arf6-specific antibody included in the kit. |
|||
Arf6 Activation Assay Kit, Trial Size |
|||
STA-407-6-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Arf Activation Assays use visible agarose beads to selectively precipitate the active form of Arf1 or Arf 6. The precipitated small GTPase is then detected by Western blot using an Arf1- or Arf6-specific antibody included in the kit. |
|||
Ral Activation Assay Kit, Trial Size |
|||
STA-408-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Ral Activation Assay uses visible agarose beads to selectively precipitate the active form of Ral protein. The precipitated small GTPase is then detected by Western blot using a Ral-specific antibody included in the kit. |
|||
Ran Activation Assay Kit, Trial Size |
|||
STA-409-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Ran Activation Assay uses visible agarose beads to selectively precipitate the active form of Ran protein. The precipitated small GTPase is then detected by Western blot using a Ran-specific antibody included in the kit. |
|||
H-Ras Activation Assay Kit, Trial Size |
|||
STA-400-H-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Ras Activation Assays use visible agarose beads to selectively precipitate the active form of specific Ras protein of interest. The precipitated small GTPase is then detected by Western blot using a target-specific antibody included in the kit. Assays are available to detect specific isoforms H-Ras, K-Ras, and N-Ras, as well as a Pan-Ras assay that detects all three isoforms. |
|||
K-Ras Activation Assay Kit, Trial Size |
|||
STA-400-K-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Ras Activation Assays use visible agarose beads to selectively precipitate the active form of specific Ras protein of interest. The precipitated small GTPase is then detected by Western blot using a target-specific antibody included in the kit. Assays are available to detect specific isoforms H-Ras, K-Ras, and N-Ras, as well as a Pan-Ras assay that detects all three isoforms. |
|||
N-Ras Activation Assay Kit, Trial Size |
|||
STA-400-N-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Ras Activation Assays use visible agarose beads to selectively precipitate the active form of specific Ras protein of interest. The precipitated small GTPase is then detected by Western blot using a target-specific antibody included in the kit. Assays are available to detect specific isoforms H-Ras, K-Ras, and N-Ras, as well as a Pan-Ras assay that detects all three isoforms. |
|||
Pan-Ras Activation Assay Kit, Trial Size |
|||
STA-400-T | Cell Biolabs | 5 assays | 483.6 EUR |
Description: Our Ras Activation Assays use visible agarose beads to selectively precipitate the active form of specific Ras protein of interest. The precipitated small GTPase is then detected by Western blot using a target-specific antibody included in the kit. Assays are available to detect specific isoforms H-Ras, K-Ras, and N-Ras, as well as a Pan-Ras assay that detects all three isoforms. |
|||
RhoA/Rac1/CDC42 Activation Assay Combo Kit |
|||
STA-405 | Cell Biolabs | 3 x 10 assays | 1305.6 EUR |
Description: Our RhoA/Rac1/Cdc42 Activation Assays use visible agarose beads to selectively precipitate the active form of the small GTPase. The precipitated small GTPase is then detected by Western blot using a specific antibody included in the kit. |
|||
96-Well Ras Activation ELISA Kit (Colorimetric) |
|||
STA-440 | Cell Biolabs | 96 assays | 1082.4 EUR |
Description: Our 96-Well Ras Activation ELISA Kit uses the Raf1 RBD (Rho binding domain) bound to a 96-well plate to selectively pull down the active form of Ras from purified or endogenous samples. The captured GTP-Ras is then detected by a pan-Ras antibody and HRP-conjugated secondary antibody. |
|||
96-Well Ras Activation ELISA Kit (Chemiluminescent) |
|||
STA-441 | Cell Biolabs | 96 assays | 1082.4 EUR |
Description: Our 96-Well Ras Activation ELISA Kit uses the Raf1 RBD (Rho binding domain) bound to a 96-well plate to selectively pull down the active form of Ras from purified or endogenous samples. The captured GTP-Ras is then detected by a pan-Ras antibody and HRP-conjugated secondary antibody. |
|||
Human NK cell ELISA kit |
|||
201-12-1973 | SunredBio | 96 tests | 528 EUR |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
NK cell ELISA KIT|Human |
|||
EF007439 | Lifescience Market | 96 Tests | 826.8 EUR |
Human NK cell ELISA Kit |
|||
GA-E1989HM-48T | GenAsia Biotech | 48T | 346.8 EUR |
Human NK cell ELISA Kit |
|||
GA-E1989HM-96T | GenAsia Biotech | 96T | 559.2 EUR |
Human NK cell ELISA Kit |
|||
QY-E04751 | Qayee Biotechnology | 96T | 433.2 EUR |
eGFP NK-92 Cell Line |
|||
78399 | BPS Bioscience | 2 vials | 3950 EUR |
Description: Recombinant stable NK-92 cell line constitutively expressing enhanced Green Fluorescent Protein (eGFP). The cell line was generated using the eGFP Lentivirus ( BPS Bioscience #79979). Expression is driven by a CMV promoter. |
|||
NK 252 |
|||
C5715-10 | ApexBio | 10 mg | 268.8 EUR |
Description: NK 252 is an Nrf2 activator [1][2]. NK 252 is an Nrf2 activator that interacts directly with the domain containing the Nrf2-binding site of Keap1. Keap1 is a cytosolic repressor of Nrf2 that retains Nrf2 in the cytoplasm [1]. |
|||
NK 252 |
|||
C5715-25 | ApexBio | 25 mg | 529.2 EUR |
Description: NK 252 is an Nrf2 activator [1][2]. NK 252 is an Nrf2 activator that interacts directly with the domain containing the Nrf2-binding site of Keap1. Keap1 is a cytosolic repressor of Nrf2 that retains Nrf2 in the cytoplasm [1]. |
|||
NK 252 |
|||
C5715-5 | ApexBio | 5 mg | 174 EUR |
Description: NK 252 is an Nrf2 activator [1][2]. NK 252 is an Nrf2 activator that interacts directly with the domain containing the Nrf2-binding site of Keap1. Keap1 is a cytosolic repressor of Nrf2 that retains Nrf2 in the cytoplasm [1]. |
|||
NK-1.1 |
|||
MONKA(V100) | ImmunoStep | 100 ug | 60 EUR |
NK-1.1 |
|||
MONKA(V25) | ImmunoStep | 25 ug | 60 EUR |
NK-1.1 |
|||
MONKB(V100) | ImmunoStep | 100 ug | 60 EUR |
NK-1.1 |
|||
MONKB(V25) | ImmunoStep | 25 ug | 60 EUR |
NK-1.1 |
|||
MONKCFB(V100) | ImmunoStep | 100 ug | 60 EUR |
NK-1.1 |
|||
MONKCFB(V25) | ImmunoStep | 25 ug | 60 EUR |
NK-1.1 |
|||
MONKF(V100) | ImmunoStep | 100 ug | 60 EUR |
NK-1.1 |
|||
MONKF(V25) | ImmunoStep | 25 ug | 60 EUR |
NK-1.1 |
|||
MONKF(V500) | ImmunoStep | 500 ug | 60 EUR |
NK-1.1 |
|||
MONKPE(V100) | ImmunoStep | 100 ug | 60 EUR |
NK-1.1 |
|||
MONKPE(V25) | ImmunoStep | 25 ug | 60 EUR |
NK-1.1 |
|||
MONKPP(V100) | ImmunoStep | 100 ug | 60 EUR |
NK-1.1 |
|||
MONKPP(V25) | ImmunoStep | 25 ug | 60 EUR |
NK-1.1 |
|||
MONKPP5.5(V100) | ImmunoStep | 100 ug | 60 EUR |
NK-1.1 |
|||
MONKPP5.5(V25) | ImmunoStep | 25 ug | 60 EUR |
NK-1.1 |
|||
MONKPU(V100) | ImmunoStep | 100 ug | 60 EUR |
NK-1.1 |
|||
MONKPU(V500) | ImmunoStep | 500 ug | 60 EUR |
NK-252 |
|||
HY-19734 | MedChemExpress | 100mg | 854.4 EUR |
MagIso NK Cell Isolation Kit, Human |
|||
WHK-B023 | Creative Diagnostics | 20 tests, 200 tests | Ask for price |
Firefly Luciferase NK-92 Cell Line |
|||
78400 | BPS Bioscience | 2 vials | 3950 EUR |
Description: Recombinant stable NK-92 cell line constitutively expressing firefly (Photinus pyralis) luciferase under the control of a CMV promoter. |
|||
LowRange Rainbow Molecular Weight Markers 250ul |
|||
RPN755E | Scientific Laboratory Supplies | EACH | 223.44 EUR |
HighRange Rainbow Molecular Weight Markers 250ul |
|||
RPN756E | Scientific Laboratory Supplies | EACH | 223.44 EUR |
HighRange Rainbow Molecular Weight Markers 250ul |
|||
RPN800E | Scientific Laboratory Supplies | EACH | 238.26 EUR |
Amersham ECL DualVue Western Blotting Markers |
|||
RPN810 | Scientific Laboratory Supplies | EACH | 223.44 EUR |
NK-1.1 Antibody |
|||
20-abx201032 | Abbexa |
|
|
Human Nature Killer Cell (NK cell) ELISA Kit |
|||
abx257238-96tests | Abbexa | 96 tests | 764.4 EUR |
Monoclonal CD57 Antibody [Clone NK-1], Clone: NK-1 |
|||
AMM00170G | Leading Biology | 0.1mg | 580.8 EUR |
Description: A Monoclonal antibody against Human CD57 [Clone NK-1]. The antibodies are raised in Mouse and are from clone NK-1. This antibody is applicable in WB, IHC and IF, FC |
|||
Human natural killer cell?NK ELISA Kit |
|||
201-12-2129 | SunredBio | 96 tests | 528 EUR |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human NK Cell Mediated Toxicity Primer Library |
|||
HNKT-I | Real Time Primers | 1 set | 657.6 EUR |
Human natural killer cell(NK)ELISA Kit |
|||
QY-E00072 | Qayee Biotechnology | 96T | 433.2 EUR |
Rat natural killer cell(NK)ELISA Kit |
|||
QY-E10572 | Qayee Biotechnology | 96T | 433.2 EUR |
Mouse natural killer cell(NK)ELISA Kit |
|||
QY-E21055 | Qayee Biotechnology | 96T | 433.2 EUR |
Rat natural killer cell(NK)ELISA Kit |
|||
YLA1679RA-48T | Shanghai YL Biotech | 48T | 465 EUR |
Rat natural killer cell(NK)ELISA Kit |
|||
YLA1679RA-96T | Shanghai YL Biotech | 96T | 600 EUR |
Human natural killer cell(NK)ELISA Kit |
|||
YLA1909HU-48T | Shanghai YL Biotech | 48T | 435 EUR |
Human natural killer cell(NK)ELISA Kit |
|||
YLA1909HU-96T | Shanghai YL Biotech | 96T | 562.5 EUR |
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
201-12-1660 | SunredBio | 96 tests | 528 EUR |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
CSB-E04774h-24T | Cusabio | 1 plate of 24 wells | 198 EUR |
Description: Quantitativesandwich ELISA kit for measuring Human Pancreatic carcinoma markers-CA242 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
1-CSB-E04774h | Cusabio |
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Pancreatic carcinoma markers-CA242 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
GA-E1676HM-48T | GenAsia Biotech | 48T | 346.8 EUR |
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
GA-E1676HM-96T | GenAsia Biotech | 96T | 559.2 EUR |
Human Pancreatic carcinoma markers-CA242 ELISA Kit |
|||
QY-E00484 | Qayee Biotechnology | 96T | 433.2 EUR |
Amersham ECL Plex Fluorescent Rainbow Markers 500ul |
|||
RPN851E | Scientific Laboratory Supplies | EACH | 273.6 EUR |
NK-1R Polyclonal Antibody |
|||
41243-100ul | SAB | 100ul | 302.4 EUR |
NK-1R Polyclonal Antibody |
|||
41243-50ul | SAB | 50ul | 224.4 EUR |
NK-TR Polyclonal Antibody |
|||
ABP55394-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of NK-TR from Human. This NK-TR antibody is for IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human NK-TR at AA range: 760-840 |
|||
NK-TR Polyclonal Antibody |
|||
ABP55394-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of NK-TR from Human. This NK-TR antibody is for IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human NK-TR at AA range: 760-840 |
|||
NK-TR Polyclonal Antibody |
|||
ABP55394-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of NK-TR from Human. This NK-TR antibody is for IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human NK-TR at AA range: 760-840 |
|||
NK-3R Polyclonal Antibody |
|||
ABP51965-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of NK-3R from Human, Mouse, Rat. This NK-3R antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human NK-3R at AA range: 370-450 |
|||
NK-3R Polyclonal Antibody |
|||
ABP51965-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of NK-3R from Human, Mouse, Rat. This NK-3R antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human NK-3R at AA range: 370-450 |
|||
NK-3R Polyclonal Antibody |
|||
ABP51965-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of NK-3R from Human, Mouse, Rat. This NK-3R antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human NK-3R at AA range: 370-450 |
|||
NK-2R Polyclonal Antibody |
|||
ABP56329-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of NK-2R from Human. This NK-2R antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human NK-2R at AA range: 270-350 |
|||
NK-2R Polyclonal Antibody |
|||
ABP56329-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of NK-2R from Human. This NK-2R antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human NK-2R at AA range: 270-350 |
|||
NK-2R Polyclonal Antibody |
|||
ABP56329-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of NK-2R from Human. This NK-2R antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human NK-2R at AA range: 270-350 |
|||
NK-1R Polyclonal Antibody |
|||
ABP56334-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of NK-1R from Human, Mouse, Rat. This NK-1R antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human NK-1R at AA range: 180-260 |
|||
NK-1R Polyclonal Antibody |
|||
ABP56334-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of NK-1R from Human, Mouse, Rat. This NK-1R antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human NK-1R at AA range: 180-260 |
|||
NK-1R Polyclonal Antibody |
|||
ABP56334-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of NK-1R from Human, Mouse, Rat. This NK-1R antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human NK-1R at AA range: 180-260 |
|||
NK-3R Polyclonal Antibody |
|||
ABP57531-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of NK-3R from Human, Mouse, Rat. This NK-3R antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from NK-3R at AA range: 291-340 |
|||
NK-3R Polyclonal Antibody |
|||
ABP57531-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of NK-3R from Human, Mouse, Rat. This NK-3R antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from NK-3R at AA range: 291-340 |
|||
NK-3R Polyclonal Antibody |
|||
ABP57531-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of NK-3R from Human, Mouse, Rat. This NK-3R antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from NK-3R at AA range: 291-340 |
|||
NK-1.1 Antibody (APC) |
|||
20-abx201025 | Abbexa |
|
|
NK-1.1 Antibody (Biotin) |
|||
20-abx201026 | Abbexa |
|
|
NK-1.1 Antibody (FITC) |
|||
20-abx201028 | Abbexa |
|
|
NK-1.1 Antibody (PE) |
|||
20-abx201029 | Abbexa |
|
|
NK-1.1 Antibody (PerCP) |
|||
20-abx201030 | Abbexa |
|
|
NK-3R Polyclonal Antibody |
|||
ES2964-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against NK-3R from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
|||
NK-3R Polyclonal Antibody |
|||
ES2964-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against NK-3R from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
|||
Porcine NK ELISA Kit |
|||
EPN0030 | Abclonal | 96Tests | 625.2 EUR |
Rabbit NK ELISA Kit |
|||
ERTN0030 | Abclonal | 96Tests | 625.2 EUR |
Rat NK ELISA Kit |
|||
ERN0030 | Abclonal | 96Tests | 625.2 EUR |
Mouse NK ELISA Kit |
|||
EMN0030 | Abclonal | 96Tests | 625.2 EUR |
Human NK ELISA Kit |
|||
EHN0030 | Abclonal | 96Tests | 625.2 EUR |
Goat NK ELISA Kit |
|||
EGTN0030 | Abclonal | 96Tests | 625.2 EUR |
CD160/NK receptor BY55 |
|||
E21-A35 | EnoGene | 10ug | 411.6 EUR |
Bovine NK ELISA Kit |
|||
EBN0030 | Abclonal | 96Tests | 625.2 EUR |
Canine NK ELISA Kit |
|||
ECN0030 | Abclonal | 96Tests | 625.2 EUR |
Anserine NK ELISA Kit |
|||
EAN0030 | Abclonal | 96Tests | 625.2 EUR |
NK-3R Polyclonal Antibody |
|||
ES8524-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against NK-3R from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
NK-3R Polyclonal Antibody |
|||
ES8524-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against NK-3R from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
NK-2R Polyclonal Antibody |
|||
ES7328-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against NK-2R from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
|||
NK-2R Polyclonal Antibody |
|||
ES7328-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against NK-2R from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
|||
NK-1R Polyclonal Antibody |
|||
ES7333-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against NK-1R from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
|||
NK-1R Polyclonal Antibody |
|||
ES7333-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against NK-1R from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
Conclusions: Data on HIV prevalence among persons with disabilities is rare. In addition, inclusion of this population in National Strategic Plans in East and Southern African countries is often lacking specific detail.Implications for rehabilitationHIV prevalence studies in sub-Saharan Africa among persons with disabilities are rare and community studies do not disaggregate by type of disability.Estimates of HIV prevalence among persons with disabilities are greater than national averages.
Government National HIV Strategic Plans often mention persons with disabilities as a vulnerable population but less often identify specific interventions or inclusive strategies for prevention or care.
The integration of attention to disability in national HIV bio-behavioral surveys would allow increased understanding of HIV vulnerability and prevalence and could increase attention to persons with disabilities as a key population within National Strategic Plans.